ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed
Chengcheng Wang
Matched on ORCID iD 0000-0002-4226-2012; OpenAlex author ID A5100389598. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2019: 1 paper · 2020: none · 2021: 2 papers · 2022: none · 2023: 1 paper
Papers 4
- A commentary on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’ First author DOI 10.1097/js9.0000000000000633↗
- High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis. Co-author DOI 10.1186/s13045-021-01131-0↗
- S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cancer. First author DOI 10.3389/fimmu.2021.758004↗
- New Insight into the Role of Exosomes in Pancreatic Cancer. Co-author PMID 31308040↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruiyuan Xu · 3 shared papers, 2021–2023 · strength 0.59
- Paper A commentary on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’ DOI 10.1097/js9.0000000000000633↗
- Paper S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cance… DOI 10.3389/fimmu.2021.758004↗
- Paper High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis. DOI 10.1186/s13045-021-01131-0↗
- Yupei Zhao · 3 shared papers, 2021–2023 · strength 0.59
- Paper A commentary on ‘Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection’ DOI 10.1097/js9.0000000000000633↗
- Paper S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cance… DOI 10.3389/fimmu.2021.758004↗
- Paper High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis. DOI 10.1186/s13045-021-01131-0↗
- Yuan Chen · 2 shared papers, 2021 · strength 0.28
- Paper S100A2 Is a Prognostic Biomarker Involved in Immune Infiltration and Predict Immunotherapy Response in Pancreatic Cance… DOI 10.3389/fimmu.2021.758004↗
- Paper High-resolution Hi-C maps highlight multiscale 3D epigenome reprogramming during pancreatic cancer metastasis. DOI 10.1186/s13045-021-01131-0↗
- Jianlu Song · 1 shared paper, 2021 · strength 0.16
- Rexiati Ruze · 1 shared paper, 2021 · strength 0.16
- Yu-Pei Zhao · 1 shared paper, 2019 · strength 0.14
- Bo Ren · 1 shared paper, 2021 · strength 0.12
- Gang Yang · 1 shared paper, 2021 · strength 0.12
- Jinshou Yang · 1 shared paper, 2021 · strength 0.12
- Taiping Zhang · 1 shared paper, 2021 · strength 0.12
- Lei You · 1 shared paper, 2021 · strength 0.12
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.